VENTURA, Calif., Jan. 19, 2022 /PRNewswire/ -- 101 Hemp
(https://101hemp.org/) recently noted a promising new study from
Oregon State University already listed
by the National Institution of Health: "Cannabinoids Block Cellular
Entry of SARS-CoV-2 and the Emerging Variants." The study
explicitly concludes that raw cannabinoids CBDa and CBGa have been
shown to effectively block COVID-19 (alpha and beta) by interfering
with the virus's ability to enter human cells – thus preventing
infection. It also concludes that CBDa and CBGa hemp products are
"orally bioavailable and with a long history of safe human use,
these cannabinoids, isolated or in hemp extracts, have the
potential to prevent as well as treat infection by SARS-CoV-2."
"This is absolutely game changing news, not only for the hemp
industry, but for the world," said Justin
Benton, Founder and CEO of 101 Hemp. "Those of us in the
industry have long known the beneficial properties of raw hemp – my
own child has been treated with hemp products to help overcome an
autism diagnosis. So we're extremely gratified and relieved to see
that the scientific community is really digging into the potential
for hemp products to help fight other diseases like COVID-19. The
world is ready for natural solutions. And based on a poll that we
recently ran, 100% of our participants agree, voting 'Yes,' that
they would be willing to take CBDa and CBGa on a daily basis after
reading this latest research out of Oregon
State."
Hemp (cannabis sativa) is a worldwide source of fiber, food,
animal feed, and found in a wide variety of cosmetics, body
lotions, and many dietary supplements. Raw hemp food products do
not contain the psychoactive substance THC Delta Nine, and are
generally considered safe for normal consumption. For the latest
hemp/CBD news and hemp-derived products, follow 101 Hemp on social
media: Facebook, Instagram, YouTube.
About 101 Hemp
101 Hemp is the largest global producer
of products containing raw CBDa and CBGa products derived from
hemp, including 101 Hemp's signature Boost X Sublingual CBDa oil
with over 400% higher CBGa and over 70% more CBDa content. Explore
the products at: www.101hemp.org.
Disclaimer: These statements have not been evaluated
by the Food and Drug Administration. The efficacy of these products
has not been confirmed by FDA research. These products are not
intended to diagnose, treat, cure, or prevent any disease.
Media Contact:
Justin
Benton
1-805-296-1525
327856@email4pr.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/largest-global-maker-of-raw-cbga-and-cbda-products-101-hemp-highlights-breakthrough-research-by-oregon-state-university-on-the-use-of-cannabinoids-to-prevent-covid-19-infection-301464116.html
SOURCE 101 Hemp